Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Historic Restructuring Costs for Solid Biosciences (SLDB) over the last 3 years, with Q2 2023 value amounting to -$63000.0.

  • Solid Biosciences' Restructuring Costs fell 10414.47% to -$63000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $5.6 million, marking a year-over-year decrease of 2205.35%. This contributed to the annual value of -$63000.0 for FY2023, which is 10087.77% down from last year.
  • As of Q2 2023, Solid Biosciences' Restructuring Costs stood at -$63000.0, which was down 10414.47% from $5.7 million recorded in Q4 2022.
  • In the past 5 years, Solid Biosciences' Restructuring Costs ranged from a high of $5.7 million in Q4 2022 and a low of -$63000.0 during Q2 2023
  • In the last 3 years, Solid Biosciences' Restructuring Costs had a median value of $1.7 million in 2020 and averaged $2.3 million.
  • Examining YoY changes over the last 5 years, Solid Biosciences' Restructuring Costs showed a top increase of 10414.47% in 2023 and a maximum decrease of 10414.47% in 2023.
  • Solid Biosciences' Restructuring Costs (Quarter) stood at $1.9 million in 2020, then skyrocketed by 191.05% to $5.7 million in 2022, then plummeted by 101.11% to -$63000.0 in 2023.
  • Its Restructuring Costs stands at -$63000.0 for Q2 2023, versus $5.7 million for Q4 2022 and $1.5 million for Q2 2022.